Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay.

PubWeight™: 1.39‹?› | Rank: Top 10%

🔗 View Article (PMID 3049839)

Published in J Infect Dis on October 01, 1988

Authors

V P Berardi1, K E Weeks, A C Steere

Author Affiliations

1: Department of Virology, Center for Disease Control, Boston, Massachusetts 02130.

Articles citing this

Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med (2013) 2.54

Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella. J Clin Microbiol (1991) 1.36

Lyme disease assay which detects killed Borrelia burgdorferi. J Clin Microbiol (1991) 1.36

Comparison of indirect immunofluorescent-antibody assay, enzyme-linked immunosorbent assay, and Western immunoblot for the diagnosis of Lyme disease in dogs. J Clin Microbiol (1990) 1.21

Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol (1992) 1.11

Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. J Clin Microbiol (1994) 1.06

A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol Pathol (1997) 1.00

Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. J Clin Microbiol (2001) 0.97

Adsorption and biotin-streptavidin amplification in serologic tests for diagnosis of Lyme borreliosis. J Clin Microbiol (1991) 0.88

Ovalbumin blocking improves sensitivity and specificity of immunoglobulin M immunoblotting for serodiagnosis of patients with erythema migrans. J Clin Microbiol (1992) 0.87

Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope. J Clin Microbiol (1998) 0.86

Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clin Diagn Lab Immunol (1994) 0.85

Surface immunofluorescence assay for diagnosis of Lyme disease. J Clin Microbiol (1992) 0.85

Detection of borreliacidal antibodies in hamsters by using flow cytometry. J Clin Microbiol (1992) 0.82

2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts. Ann Rheum Dis (1993) 0.81

Expression of public idiotypes in patients with Lyme arthritis. Ann Rheum Dis (1993) 0.80

Laboratory confirmation of Lyme disease. Can J Infect Dis (1991) 0.78

Utilization of tests for Lyme disease antibody at a university hospital. Clin Diagn Lab Immunol (1996) 0.77

The diagnosis of Lyme disease. J R Soc Med (1995) 0.75

Articles by these authors

(truncated to the top 100)

The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59

Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum (1977) 9.14

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med (1977) 7.42

Western blotting in the serodiagnosis of Lyme disease. J Infect Dis (1993) 6.45

The early clinical manifestations of Lyme disease. Ann Intern Med (1983) 5.73

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest (1986) 5.72

Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini. Ann Intern Med (1979) 4.73

Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med (1980) 4.12

Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. J Clin Invest (1983) 4.08

Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis (1988) 4.08

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med (1994) 4.07

Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis (1984) 4.07

Neurologic abnormalities of Lyme disease. Medicine (Baltimore) (1979) 3.98

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68

The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology (1985) 3.55

Chronic neurologic manifestations of Lyme disease. N Engl J Med (1990) 3.54

Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41

The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun (1993) 3.04

Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J Infect Dis (1988) 3.02

Antibiotic therapy in Lyme disease. Ann Intern Med (1980) 2.93

A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (1986) 2.91

Treatment of the early manifestations of Lyme disease. Ann Intern Med (1983) 2.89

DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71

Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immun (1994) 2.57

Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol (1978) 2.53

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med (1993) 2.52

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med (1983) 2.50

Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med (1997) 2.48

Diagnosing early Lyme disease. Am J Med (1985) 2.41

Handwashing practices for the prevention of nosocomial infections. Ann Intern Med (1975) 2.36

Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34

Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23

Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21

Treatment of early Lyme disease. Am J Med (1992) 2.18

Clinical pathologic correlations of Lyme disease by stage. Ann N Y Acad Sci (1988) 2.16

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet (1993) 2.05

Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann Intern Med (1985) 2.04

Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol (1985) 2.03

Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum (1999) 2.01

Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95

High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol (1988) 1.86

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis (2000) 1.82

Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med (1979) 1.79

The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun (1999) 1.79

Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med (1979) 1.79

The T-cell proliferative assay in the diagnosis of Lyme disease. Ann Intern Med (1991) 1.70

Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum (1979) 1.70

The clinical spectrum and treatment of Lyme disease. Yale J Biol Med (1985) 1.70

Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun (1995) 1.68

The long-term course of Lyme arthritis in children. N Engl J Med (1991) 1.63

Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A (2000) 1.61

An animal model for Lyme arthritis. Ann N Y Acad Sci (1988) 1.60

Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J Infect Dis (1986) 1.56

Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol (1998) 1.53

Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity. N Engl J Med (1979) 1.53

Lyme disease. Adv Intern Med (1995) 1.49

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis (2001) 1.45

Recovery of Lyme disease spirochetes from patients. Yale J Biol Med (1985) 1.42

Pseudomonas species bacteremia caused by contaminated normal human serum albumin. J Infect Dis (1977) 1.42

Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis (1994) 1.41

The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med (1994) 1.41

Elevated levels of collagenase and prostaglandin E2 from synovium associated with erosion of cartilage and bone in a patient with chronic Lyme arthritis. Arthritis Rheum (1980) 1.38

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis (1990) 1.36

T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol (1998) 1.35

Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun (2001) 1.32

Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. Arthritis Rheum (1986) 1.31

Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum (1999) 1.27

Arthritis caused by Borrelia burgdorferi in dogs. J Am Vet Med Assoc (1985) 1.26

Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. J Clin Invest (1979) 1.26

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest (1992) 1.26

[Spirochete etiology of erythema chronicum migrans disease]. Dtsch Med Wochenschr (1984) 1.23

Neurological findings of Lyme disease. Yale J Biol Med (1985) 1.21

Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis (1991) 1.21

Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol (2000) 1.20

Lyme disease associated with fibromyalgia. Ann Intern Med (1992) 1.18

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis (1996) 1.17

Anticardiolipin antibodies in Lyme disease. Arthritis Rheum (1988) 1.16

Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med (1985) 1.13

A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Am Rev Respir Dis (1979) 1.13

In vivo and in vitro evidence of B cell hyperactivity during Lyme disease. J Rheumatol (1988) 1.13

Expression of adhesion molecules in synovia of patients with treatment-resistant lyme arthritis. Infect Immun (2001) 1.09

Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood. Infect Immun (1984) 1.08

Nonprotein antigens of Borrelia burgdorferi. J Infect Dis (1993) 1.07

Erythema chronicum migrans and Lyme arthritis: cryoimmunoglobulins and clinical activity of skin and joints. Science (1977) 1.03

Central nervous system manifestations of Lyme disease. Arch Neurol (1989) 1.03

Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J Immunol (2001) 1.02

Infection in rabbits with the Lyme disease spirochete. Yale J Biol Med (1985) 1.01

Surveillance of Lyme disease in the United States, 1982. J Infect Dis (1985) 1.01

Evaluation of study patients with Lyme disease, 10-20-year follow-up. J Infect Dis (2000) 1.00

Ixodes ricinus spirochete and European erythema chronicum migrans disease. Yale J Biol Med (1985) 0.98

The antibody response in Lyme disease. Yale J Biol Med (1985) 0.98

Host metalloproteinases in Lyme arthritis. Arthritis Rheum (2001) 0.98

Newly recognized Leptospira species ("Leptospira inadai" serovar lyme) isolated from human skin. J Clin Microbiol (1986) 0.98

Test-treatment strategies for patients suspected of having Lyme disease: a cost-effectiveness analysis. Ann Intern Med (1998) 0.97

T cell responses to polypeptide fractions of Borrelia burgdorferi in patients with Lyme arthritis. Arthritis Rheum (1991) 0.97

Ultrastructural differences among spirochetes isolated from patients with Lyme disease and related disorders, and from Ixodes ricinus. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.97

Lyme borreliosis in the Soviet Union: a cooperative US-USSR report. J Infect Dis (1988) 0.97

Cellular immune findings in Lyme disease. Correlation with serum IgM and disease activity. Am J Med (1984) 0.96

Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann Intern Med (1988) 0.96